{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T16:13:52Z","timestamp":1785428032430,"version":"3.56.0"},"reference-count":83,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002461","name":"Chungbuk National University","doi-asserted-by":"publisher","award":["2022"],"award-info":[{"award-number":["2022"]}],"id":[{"id":"10.13039\/501100002461","id-type":"DOI","asserted-by":"publisher"}]},{"award":["2022"],"award-info":[{"award-number":["2022"]}],"id":[{"id":"https:\/\/ror.org\/02wnxgj78","id-type":"ROR","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2022R1C1C1002933"],"award-info":[{"award-number":["2022R1C1C1002933"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"award":["2022R1C1C1002933"],"award-info":[{"award-number":["2022R1C1C1002933"]}],"id":[{"id":"https:\/\/ror.org\/013aysd81","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Hepatocellular carcinoma is challenging to detect at an early stage, and its severity increases over time. Recently, the incidence of hepatocellular carcinoma has increased, partly due to lifestyle-related factors such as excessive alcohol intake, sedentary behavior, and diets high in fat, which contribute to the growing prevalence of fatty liver and hepatitis. Various therapeutic strategies are being explored for hepatocellular carcinoma, among which therapies targeting deubiquitinating enzymes (DUBs) have attracted growing attention. Ubiquitination acts as a crucial modulator in the regulation of intracellular signaling across many diseases. E3 ligase recognizes the target protein and transfers ubiquitin, received from the E2 enzyme, to the lysine residues of the substrate, thereby conferring specificity to the ubiquitination process. Once a ubiquitin chain is attached to a target protein by an E3 ligase, the protein is directed to the ubiquitin\u2013proteasome system (UPS) for degradation. In this process, the 26S proteasome complex recognizes the ubiquitin chain and degrades the target protein, thereby serving as a major mechanism for maintaining protein homeostasis. Through this pathway, cells regulate signal transduction, eliminate abnormal proteins, and perform various essential functions. On the other hand, deubiquitinating enzymes (DUBs) recognize the ubiquitin chains on target proteins and remove them by hydrolyzing the isopeptide bonds of ubiquitin, thereby enabling the target proteins to evade degradation by the proteasome system. Furthermore, deubiquitinating enzymes independently remove ubiquitin from proteins and can serve as central regulators in signaling pathways related to hepatocellular carcinoma.<\/jats:p>","DOI":"10.3390\/ijms27125625","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T03:09:17Z","timestamp":1782270557000},"page":"5625","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Deubiquitinating Enzymes as Therapeutic Candidates in Hepatocellular Carcinoma and Other Liver Disease"],"prefix":"10.3390","volume":"27","author":[{"given":"Young-Hoon","family":"Jeong","sequence":"first","affiliation":[{"name":"College of Pharmacy, Chungbuk National University, Osongsaengmyeong 1-ro, Osong-eup, Heungdeok-gu, Cheongju-si 28160, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwa-Hyeong","family":"Lee","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Chungbuk National University, Osongsaengmyeong 1-ro, Osong-eup, Heungdeok-gu, Cheongju-si 28160, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4225-126X","authenticated-orcid":false,"given":"Young-Jun","family":"Kim","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Chungbuk National University, Osongsaengmyeong 1-ro, Osong-eup, Heungdeok-gu, Cheongju-si 28160, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye-Rim","family":"Lee","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Chungbuk National University, Osongsaengmyeong 1-ro, Osong-eup, Heungdeok-gu, Cheongju-si 28160, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3636-379X","authenticated-orcid":false,"given":"Key-Hwan","family":"Lim","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Chungbuk National University, Osongsaengmyeong 1-ro, Osong-eup, Heungdeok-gu, Cheongju-si 28160, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1140126","DOI":"10.3389\/fcimb.2023.1140126","article-title":"Intestinal flora plays a role in the progression of hepatitis-cirrhosis-liver cancer","volume":"13","author":"Liu","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"a021535","DOI":"10.1101\/cshperspect.a021535","article-title":"Treatment of Liver Cancer","volume":"5","author":"Liu","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"102446","DOI":"10.1016\/j.jceh.2024.102446","article-title":"Global Epidemiology of Hepatocellular Carcinoma","volume":"15","author":"Singh","year":"2025","journal-title":"J. Clin. Exp. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e18017","DOI":"10.1111\/jcmm.18017","article-title":"USP11 promotes glycolysis by regulating HIF-1alpha stability in hepatocellular carcinoma","volume":"28","author":"Qiao","year":"2024","journal-title":"J. Cell. Mol. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"316","DOI":"10.5483\/BMBRep.2022.55.7.054","article-title":"Ubiquitin-regulating effector proteins from Legionella","volume":"55","author":"Jeong","year":"2022","journal-title":"BMB Rep."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.apsb.2025.01.010","article-title":"The ubiquitin-proteasome system: A potential target for the MASLD","volume":"15","author":"Liu","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1038\/s41418-021-00754-7","article-title":"Deubiquitinase USP39 and E3 ligase TRIM26 balance the level of ZEB1 ubiquitination and thereby determine the progression of hepatocellular carcinoma","volume":"28","author":"Li","year":"2021","journal-title":"Cell Death Differ."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3390\/biom11010060","article-title":"The Ubiquitin-Proteasome System in Immune Cells","volume":"11","author":"Cetin","year":"2021","journal-title":"Biomolecules"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12943-020-01262-x","article-title":"The role of ubiquitination and deubiquitination in cancer metabolism","volume":"19","author":"Sun","year":"2020","journal-title":"Mol. Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.biopsych.2022.03.022","article-title":"The DUB Club: Deubiquitinating Enzymes and Neurodevelopmental Disorders","volume":"92","author":"Jolly","year":"2022","journal-title":"Biol. Psychiatry"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41416-021-01516-5","article-title":"UCHL1 as a novel target in breast cancer: Emerging insights from cell and chemical biology","volume":"126","author":"Mondal","year":"2022","journal-title":"Br. J. Cancer"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"S4210","DOI":"10.4103\/jpbs.jpbs_517_24","article-title":"Deubiquitinases and Cancer","volume":"16","author":"Murali","year":"2024","journal-title":"J. Pharm. Bioallied Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"920287","DOI":"10.3389\/fonc.2022.920287","article-title":"Research Progress of DUB Enzyme in Hepatocellular Carcinoma","volume":"12","author":"Zhao","year":"2022","journal-title":"Front. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"109049","DOI":"10.1016\/j.bioorg.2025.109049","article-title":"Unraveling the mechanisms of ubiquitin-specific proteases in hepatocellular carcinoma: A focus on inhibitors","volume":"165","author":"Xu","year":"2025","journal-title":"Bioorg. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e2303807","DOI":"10.1002\/advs.202303807","article-title":"Deubiquitylating Enzymes in Cancer and Immunity","volume":"10","author":"Ren","year":"2023","journal-title":"Adv. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1007\/s11427-025-3100-1","article-title":"Deubiquitinases in liver diseases: From mechanisms to targeted therapy","volume":"69","author":"Zhang","year":"2026","journal-title":"Sci. China Life Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/s41419-023-05777-1","article-title":"USP1 modulates hepatocellular carcinoma progression via the Hippo\/TAZ axis","volume":"14","author":"Liu","year":"2023","journal-title":"Cell Death Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"dev201509","DOI":"10.1242\/dev.201509","article-title":"SIX1+PAX3+ identify a progenitor for myogenic lineage commitment from hPSCs","volume":"150","author":"Jaime","year":"2023","journal-title":"Development"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/s41419-022-05341-3","article-title":"Inhibition of USP1 activates ER stress through Ubi-protein aggregation to induce autophagy and apoptosis in HCC","volume":"13","author":"Wang","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"108865","DOI":"10.1016\/j.pharmthera.2025.108865","article-title":"USP1 inhibition: A journey from target discovery to clinical translation","volume":"271","author":"Torrado","year":"2025","journal-title":"Pharmacol. Ther."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1573406413666171020115539","article-title":"USP7: Target Validation and Drug Discovery for Cancer Therapy","volume":"14","author":"Zhou","year":"2018","journal-title":"Med. Chem."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Xu, Z., Gan, J., Wang, S., Zhou, Y., Liu, Y., Zhou, L., Qi, G., and Huang, Z. (Acta Biochim. Biophys. Sin., 2026). USP7 deubiquitinates Aurora B and promotes hepatocellular carcinoma progression, Acta Biochim. Biophys. Sin., Online ahead of print.","DOI":"10.3724\/abbs.2026003"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/liv.15346","article-title":"TRIM27-USP7 complex promotes tumour progression via STAT3 activation in human hepatocellular carcinoma","volume":"43","author":"Sakamoto","year":"2023","journal-title":"Liver Int."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e012287","DOI":"10.1136\/jitc-2025-012287","article-title":"Therapeutic inhibition of USP7 promotes antitumor immune responses","volume":"13","author":"Muchowicz","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.21037\/tcr-23-153","article-title":"Role for ubiquitin-specific protease 7 (USP7) in the treatment and the immune response to hepatocellular carcinoma: Potential mechanisms","volume":"12","author":"Ying","year":"2023","journal-title":"Transl. Cancer Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/mc.23527","article-title":"AKR1C3 suppresses ferroptosis in hepatocellular carcinoma through regulation of YAP\/SLC7A11 signaling pathway","volume":"62","author":"Chen","year":"2023","journal-title":"Mol. Carcinog."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.7150\/ijbs.113193","article-title":"Deubiquitylating Enzymes in Hepatocellular Carcinoma","volume":"21","author":"Mi","year":"2025","journal-title":"Int. J. Biol. Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1158\/0008-5472.CAN-20-2480","article-title":"A Positive Feedback Loop of AKR1C3-Mediated Activation of NF-kappaB and STAT3 Facilitates Proliferation and Metastasis in Hepatocellular Carcinoma","volume":"81","author":"Zhou","year":"2021","journal-title":"Cancer Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41388-023-02847-8","article-title":"USP11 potentiates HGF\/AKT signaling and drives metastasis in hepatocellular carcinoma","volume":"43","author":"Chen","year":"2024","journal-title":"Oncogene"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Bosutti, A., Dapas, B., Grassi, G., Bussani, R., Zanconati, F., Giudici, F., Bottin, C., Pavan, N., Trombetta, C., and Scaggiante, B. (2022). High eEF1A1 Protein Levels Mark Aggressive Prostate Cancers and the In Vitro Targeting of eEF1A1 Reveals the eEF1A1-actin Complex as a New Potential Target for Therapy. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23084143"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.ijrobp.2024.01.220","article-title":"USP11 Exacerbates Radiation-Induced Pneumonitis by Activating Endothelial Cell Inflammatory Response via OTUD5-STING Signaling","volume":"119","author":"Tang","year":"2024","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/s41419-025-08266-9","article-title":"USP11 promotes colorectal cancer progression by stabilizing EGFR and TRAF6: A potential therapeutic target in EGFR- and TLR-driven tumorigenesis","volume":"16","author":"Shin","year":"2025","journal-title":"Cell Death Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"5644","DOI":"10.1038\/s41467-022-33285-x","article-title":"USP14 promotes tryptophan metabolism and immune suppression by stabilizing IDO1 in colorectal cancer","volume":"13","author":"Shi","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Zhang, N., Zhang, H., Yang, X., Xue, Q., Wang, Q., Chang, R., Zhu, L., Chen, Z., and Liu, X. (2024). USP14 exhibits high expression levels in hepatocellular carcinoma and plays a crucial role in promoting the growth of liver cancer cells through the HK2\/AKT\/P62 axis. BMC Cancer, 24.","DOI":"10.1186\/s12885-024-12009-y"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s41419-025-07807-6","article-title":"Targeting the TRIM14\/USP14 axis enhances radiotherapy efficacy by inducing GPX4 degradation and disrupting ferroptotic defense in HCC","volume":"16","author":"Yue","year":"2025","journal-title":"Cell Death Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"801328","DOI":"10.3389\/fphar.2021.801328","article-title":"USP14: Structure, Function, and Target Inhibition","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1002\/hep.32518","article-title":"P53 deficiency affects cholesterol esterification to exacerbate hepatocarcinogenesis","volume":"77","author":"Zhu","year":"2023","journal-title":"Hepatology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/s41419-024-06711-9","article-title":"SOAT1 regulates cholesterol metabolism to induce EMT in hepatocellular carcinoma","volume":"15","author":"Fu","year":"2024","journal-title":"Cell Death Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1038\/s41467-022-29846-9","article-title":"USP22 regulates lipidome accumulation by stabilizing PPARgamma in hepatocellular carcinoma","volume":"13","author":"Ning","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"624112","DOI":"10.3389\/fendo.2021.624112","article-title":"PPARgamma in Metabolism, Immunity, and Cancer: Unified and Diverse Mechanisms of Action","volume":"12","author":"Broekema","year":"2021","journal-title":"Front. Endocrinol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"918314","DOI":"10.3389\/fimmu.2022.918314","article-title":"Immune Evasion and Drug Resistance Mediated by USP22 in Cancer: Novel Targets and Mechanisms","volume":"13","author":"Guo","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/s41419-023-06210-3","article-title":"USP39 promotes hepatocellular carcinogenesis through regulating alternative splicing in cooperation with SRSF6\/HNRNPC","volume":"14","author":"Zheng","year":"2023","journal-title":"Cell Death Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41419-023-05593-7","article-title":"USP39 stabilizes beta-catenin by deubiquitination and suppressing E3 ligase TRIM26 pre-mRNA maturation to promote HCC progression","volume":"14","author":"Wang","year":"2023","journal-title":"Cell Death Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e154515","DOI":"10.1172\/JCI154515","article-title":"Beta-Catenin signaling in hepatocellular carcinoma","volume":"132","author":"Xu","year":"2022","journal-title":"J. Clin. Investig."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"6384","DOI":"10.1038\/s41467-023-42040-9","article-title":"Tripartite motif containing 26 prevents steatohepatitis progression by suppressing C\/EBPdelta signalling activation","volume":"14","author":"Xu","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13062-024-00495-w","article-title":"UCHL3 promotes hepatocellular carcinoma progression by stabilizing EEF1A1 through deubiquitination","volume":"19","author":"Zhao","year":"2024","journal-title":"Biol. Direct."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/cam4.4848","article-title":"eEF1A1 promotes colorectal cancer progression and predicts poor prognosis of patients","volume":"12","author":"Fan","year":"2023","journal-title":"Cancer Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00018-024-05265-5","article-title":"UCHL3 induces radiation resistance and acquisition of mesenchymal phenotypes by deubiquitinating POLD4 in glioma stem cells","volume":"81","author":"Fan","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"117348","DOI":"10.1016\/j.biopha.2024.117348","article-title":"Research progress of the Otubains subfamily in hepatocellular carcinoma","volume":"179","author":"Wu","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/s41419-023-06287-w","article-title":"METTL3 promotes colorectal cancer progression through activating JAK1\/STAT3 signaling pathway","volume":"14","author":"Sun","year":"2023","journal-title":"Cell Death Dis."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"BSR20232147","DOI":"10.1042\/BSR20232147","article-title":"UCHL1-dependent control of hypoxia-inducible factor transcriptional activity during liver fibrosis","volume":"44","author":"Collins","year":"2024","journal-title":"Biosci. Rep."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.apsb.2022.12.006","article-title":"The deubiquitinating enzyme 13 retards non-alcoholic steatohepatitis via blocking inactive rhomboid protein 2-dependent pathway","volume":"13","author":"Xu","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e2315348121","DOI":"10.1073\/pnas.2315348121","article-title":"OTUB2 silencing promotes ovarian cancer via mitochondrial metabolic reprogramming and can be synthetically targeted by CA9 inhibition","volume":"121","author":"Nan","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1261273","DOI":"10.3389\/fmolb.2023.1261273","article-title":"OTUB1-mediated inhibition of ubiquitination: A growing list of effectors, multiplex mechanisms, and versatile functions","volume":"10","author":"Wu","year":"2023","journal-title":"Front. Mol. Biosci."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Guo, X., Yin, X., Liu, Z., and Wang, J. (2022). Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis and Natural Products for Prevention and Treatment. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232415489"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1016\/j.cmet.2024.07.014","article-title":"Amelioration of nonalcoholic fatty liver disease by inhibiting the deubiquitylating enzyme RPN11","volume":"36","author":"Zhou","year":"2024","journal-title":"Cell Metab."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Molho, M., Lin, W., and Nagy, P.D. (2021). A novel viral strategy for host factor recruitment: The co-opted proteasomal Rpn11 protein interaction hub in cooperation with subverted actin filaments are targeted to deliver cytosolic host factors for viral replication. PLoS Pathog., 17.","DOI":"10.1371\/journal.ppat.1009680"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1038\/s41598-023-30582-3","article-title":"Mangiferin relieves CCl4-induced liver fibrosis in mice","volume":"13","author":"Zhang","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Roehlen, N., Crouchet, E., and Baumert, T.F. (2020). Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives. Cells, 9.","DOI":"10.3390\/cells9040875"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Epshtein, Y., Mathew, B., Chen, W., and Jacobson, J.R. (2023). UCHL1 Regulates Radiation Lung Injury via Sphingosine Kinase-1. Cells, 12.","DOI":"10.3390\/cells12192405"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1161\/ATV.0000000000000153","article-title":"Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association","volume":"42","author":"Duell","year":"2022","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"e2302130","DOI":"10.1002\/advs.202302130","article-title":"Palmitoyltransferase ZDHHC3 Aggravates Nonalcoholic Steatohepatitis by Targeting S-Palmitoylated IRHOM2","volume":"10","author":"Xu","year":"2023","journal-title":"Adv. Sci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/cvr\/cvab041","article-title":"Deficiency of inactive rhomboid protein 2 (iRhom2) attenuates diet-induced hyperlipidaemia and early atherogenesis","volume":"118","author":"Hannemann","year":"2022","journal-title":"Cardiovasc. Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41571-021-00573-2","article-title":"Immunotherapies for hepatocellular carcinoma","volume":"19","author":"Llovet","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41392-024-02075-w","article-title":"Hepatocellular carcinoma: Signaling pathways and therapeutic advances","volume":"10","author":"Zheng","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/nrd2130","article-title":"Discovery and development of sorafenib: A multikinase inhibitor for treating cancer","volume":"5","author":"Wilhelm","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12951-025-03992-w","article-title":"Sorafenib nanomedicine in HCC: Nano-bio interactions and combination therapies","volume":"24","author":"Lu","year":"2026","journal-title":"J. Nanobiotechnol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"102434","DOI":"10.1016\/j.clinre.2024.102434","article-title":"Mechanisms of sorafenib resistance in hepatocellular carcinoma","volume":"48","author":"Liang","year":"2024","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s11523-017-0484-7","article-title":"Sorafenib: A Review in Hepatocellular Carcinoma","volume":"12","author":"Keating","year":"2017","journal-title":"Target. Oncol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.2217\/fon-2020-1290","article-title":"Atezolizumab and bevacizumab for hepatocellular carcinoma: Mechanism, pharmacokinetics and future treatment strategies","volume":"17","author":"Liu","year":"2021","journal-title":"Future Oncol."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Han, J.W., and Jang, J.W. (2023). Predicting Outcomes of Atezolizumab and Bevacizumab Treatment in Patients with Hepatocellular Carcinoma. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241411799"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Ventura, I., Sanchiz, L., Legidos-Garcia, M.E., Murillo-Llorente, M.T., and Perez-Bermejo, M. (2023). Atezolizumab and Bevacizumab Combination Therapy in the Treatment of Advanced Hepatocellular Cancer. Cancers, 16.","DOI":"10.3390\/cancers16010197"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jhep.2023.03.003","article-title":"Combination immunotherapy for hepatocellular carcinoma","volume":"79","author":"Rimassa","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"117324","DOI":"10.1016\/j.ejmech.2025.117324","article-title":"Recent advances in small molecule inhibitors of deubiquitinating enzymes","volume":"287","author":"Liu","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s10495-022-01736-x","article-title":"ML323, a USP1 inhibitor triggers cell cycle arrest, apoptosis and autophagy in esophageal squamous cell carcinoma cells","volume":"27","author":"Sun","year":"2022","journal-title":"Apoptosis"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1158\/0008-5472.CAN-24-0293","article-title":"The USP1 Inhibitor KSQ-4279 Overcomes PARP Inhibitor Resistance in Homologous Recombination-Deficient Tumors","volume":"84","author":"Cadzow","year":"2024","journal-title":"Cancer Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41389-025-00592-z","article-title":"Dual roles of USP1 in HELLS deubiquitination and SUMOylation drive EMT and FOLFOX-based chemoresistance","volume":"14","author":"Gao","year":"2025","journal-title":"Oncogenesis"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"152963","DOI":"10.1016\/j.prp.2020.152963","article-title":"Lidocaine inhibits the proliferation and invasion of hepatocellular carcinoma by downregulating USP14 induced PI3K\/Akt pathway","volume":"216","author":"Zhang","year":"2020","journal-title":"Pathol. Res. Pract."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.7150\/ijbs.96031","article-title":"Deubiquitination of CIB1 by USP14 promotes lenvatinib resistance via the PAK1-ERK1\/2 axis in hepatocellular carcinoma","volume":"20","author":"Xu","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1002\/pros.24607","article-title":"IU1 and enzalutamide combination yields synergistic effects on castration-resistant prostate cancer","volume":"83","author":"Zhang","year":"2023","journal-title":"Prostate"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/s41419-021-04089-6","article-title":"USP14 maintains HIF1-alpha stabilization via its deubiquitination activity in hepatocellular carcinoma","volume":"12","author":"Lv","year":"2021","journal-title":"Cell Death Dis."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s12964-023-01220-2","article-title":"The deubiquitinase EIF3H promotes hepatocellular carcinoma progression by stabilizing OGT and inhibiting ferroptosis","volume":"21","author":"Tang","year":"2023","journal-title":"Cell Commun. Signal."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/12\/5625\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T04:56:13Z","timestamp":1782536173000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/12\/5625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":83,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["ijms27125625"],"URL":"https:\/\/doi.org\/10.3390\/ijms27125625","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]}}}